Navigation Links
Cepheid Reports 2012 First Quarter Results
Date:4/19/2012

ss OutlookFor the fiscal year ending December 31, 2012, the Company expects:

--

 Total revenue to be in the range of $333 to $347 million; --

 Net income in the range of $0.12 to $0.17 per share;  --

Non-GAAP net income in the range of $0.50 to $0.55 per share.  Expected non-GAAP net income excludes approximately $26 million related to stock-based compensation expense, approximately $2.8 million related to the amortization of acquired intangibles, and a $1.8 million tax benefit related to an intercompany intellectual property transaction.  The fully diluted share count for the year is expected to be between 70 and 71 million.

Accessing Cepheid's First Quarter Results' Conference CallThe Company will host a management presentation at 2:00 p.m. Pacific Time on Thursday, April 19, 2012 to discuss the results.  To access the live webcast, please visit Cepheid's website at www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.

Interested participants may also listen to the live teleconference call by dialing (800) 920-8624 or (617) 597-5430, and entering participant code 71854034.  A replay will be available for seven days beginning at 4:00 p.m. Pacific Time.  Access numbers for this replay are (888) 286-8010 or (617) 801-6888, with passcode 29985463.

About CepheidBased in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests.  By automating highly complex and time-consuming
'/>"/>

SOURCE Cepheid
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Cepheid Schedules 2011 Third Quarter Financial Results Announcement and Webcast
2. Cepheid Announces Release of Updated Xpert BCR-ABL Monitor Test
3. Cepheid to Webcast Upcoming Financial Presentations
4. Cepheid Schedules 2011 Second Quarter Financial Results Announcement and Webcast
5. Cepheid CEO John Bishop Named Ernst & Young Entrepreneur Of The Year® 2011 Northern California Award winner
6. Cepheid Appoints Vice President of Infectious Disease Research & Development
7. LABSCO to Distribute Cepheid GeneXpert® Systems and Tests
8. Cepheid Appoints LABSCO as US Small Hospital Distributor
9. Cepheid Reports 2011 First Quarter Results
10. Cepheid Extends Rapid Molecular Diagnostics Leadership with FDA Clearance of Xpert Clostridium difficile/Epi
11. Cepheid Announces Nomination of Geisinger Health System CEO and Renowned Oncology Researcher to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , N.J. and NEW PROVIDENCE, N.J. ... experts will present a paper on the critical ... medical oxygen storage and deliver systems at the American ... will be held at the Chicago Sheraton Hotel and ... Derrick West , program manager of ...
(Date:9/15/2014)...  Bayer HealthCare and Orion Corporation, a pharmaceutical ... , have begun to enroll patients in a ... androgen receptor inhibitor in clinical development. The study, ... prostate cancer who have rising Prostate Specific Antigen ... is designed to determine the effects of the ...
(Date:9/15/2014)... WALTHAM, Mass. , Sept. 15, 2014  Alere Inc. ... a global leader in infectious disease, toxicology, cardiology and ... of former executives, led by former CEO Ron ... and Exchange Commission and subsequently sent a letter to ... requesting one month of due diligence in an effort ...
Breaking Medicine Technology:Linde Healthcare experts to present details on installation of medical oxygen storage and distribution systems at ASPE convention 2Linde Healthcare experts to present details on installation of medical oxygen storage and distribution systems at ASPE convention 3Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 2Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 3Alere Responds To Letter From Former Executives 2
... Unilife Corporation ("Unilife" or the "Company") (NASDAQ: ... has successfully completed the validation phase of the Unifill® ... final step in the industrialization process for the Unifill ... said: "The completion of all validation tests associated with ...
... Cayenne Medical, Inc., a private sports medicine device ... System, its second generation device for treatment of traumatic ... the 2011 American Orthopaedic Society for Sports Medicine Annual ... Tal David, MD, orthopedic sports medicine specialist, San ...
Cached Medicine Technology:Unilife Successfully Completes Industrialization of Unifill Syringe 2Unilife Successfully Completes Industrialization of Unifill Syringe 3Unilife Successfully Completes Industrialization of Unifill Syringe 4Cayenne Medical, Inc. Launches CrossFix® II Meniscal Repair System 2
(Date:9/16/2014)... is relative, especially to people who tend to be ... Medical Center in the US found that seven in ... People of normal weight make this mistake much less ... to misjudge their children,s size, as youngsters misjudge their ... at Weill-Cornell Medical College, in a study in the ...
(Date:9/16/2014)... study that compared patient-reported outcomes of a broad ... that single fraction radiation therapy (SFRT) is equally ... when pain, function and quality of life are ... American Society for Radiation Oncology,s (ASTRO,s) 56th Annual ... patients, pain, function and degree of distress were ...
(Date:9/16/2014)... While abnormalities in the adrenergic and noradrenergic systems, ... to play a role in the development of ... been no genetic evidence of this connection. A ... University,s Mailman School of Public Health and the ... ADRB2 gene and childhood adversity. For individuals with ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Beginning October 1st ... a new service offering for its clients who book a ... the volume of business they buy. Most recurring visit ... during the work week, but others include clients whose unique ... pet sitter on a daily basis. The newly ...
(Date:9/16/2014)... Philadelphia, PA (PRWEB) September 16, 2014 ... #1 Pain Management practice by Ranking Arizona magazine, has ... for implementation across its enterprise. , With TPC ... had a vast data repository that was managed through ... for both the management and clinical leadership teams. ...
Breaking Medicine News(10 mins):Health News:Poor body size judgement can lead to increased tolerance of obesity 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 3Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 4Health News:Evidence of genetic link to PTSD in soldiers exposed to childhood trauma 2Health News:Evidence of genetic link to PTSD in soldiers exposed to childhood trauma 3Health News:Dallas-based Park Cities Pet Sitter Introduces New 15-Minute Visit for Clients on Recurring Visit Schedules. 2Health News:Dallas-based Park Cities Pet Sitter Introduces New 15-Minute Visit for Clients on Recurring Visit Schedules. 3Health News:The Pain Center of Arizona (TPC) Implements Analance™ BI for Actionable Intelligence 2Health News:The Pain Center of Arizona (TPC) Implements Analance™ BI for Actionable Intelligence 3
... , MORRISTOWN, N.J., Dec. 2 ... announced that the Federal Trade Commission (FTC) has accepted a ... acquisition of privately held Arrow Group and has granted early ... the parties to close the transaction. The parties have ...
... , NASHVILLE, Tenn., Dec. 2 ... company, has appointed Pearson Talbert as chief development officer. ... will provide leadership and vision to the sales and ... hospitals grow revenues through employer partnerships and physician relationships. ...
... , MORRISTOWN, N.J., Dec. 2 Watson Pharmaceuticals, Inc. (NYSE: ... the acquisition of Arrow Group for a combination of cash ... pharmaceutical company with over $3 billion in annual revenues and ... several significant benefits to Watson shareholders as a result of ...
... taking it for macular degeneration is not advised, ... Women who take low-dose aspirin to protect their heart ... new study by Harvard University researchers found what they ... age-related macular degeneration (AMD), an eye disease that destroys ...
... ... Lighting Sunday, December 13 to remember all children who died. Hundreds of services open to ... many believe is the world,s largest mass candle lighting. , ... Oak Brook IL (PRWEB) December 2, 2009 -- Tens of ...
... ... to do better, be better and take better self-care. What to do to ensure the ... make self-care the #1 priority. At Garden of Eve safe skin care is the primary ... consumer guide to safe cosmetic products. , ...
Cached Medicine News:Health News:Watson Receives FTC Clearance for Arrow Acquisition 2Health News:Aegis Health Group Hires Pearson Talbert as Chief Development Officer 2Health News:Watson Completes Acquisition of Arrow Group 2Health News:Watson Completes Acquisition of Arrow Group 3Health News:Watson Completes Acquisition of Arrow Group 4Health News:Watson Completes Acquisition of Arrow Group 5Health News:In Women, Aspirin Might Ward Off Eye Trouble 2Health News:Bereaved Families Unite for Compassionate Friends Worldwide Candle Lighting 2Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 2Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 3Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: